Comparing Neuroendoscopy-Assisted and Burr Hole Drainage for Treating Chronic Subdural Hematoma in Adults

What this Trial Is About

Chronic subdural hematoma CSDH is a common neurosurgical condition where fluid collects between layers of the brains protective membranes, causing brain compression and neurological problems. This condition can be life-threatening if severe, and current treatments lack a clear standard due to uncertain long-term outcomes. Researchers are conducting a multicenter randomized trial to compare two surgical methods to find the best treatment approach for CSDH. The study compares neuroendoscopy-assisted hematoma drainage to conventional burr-hole drainage. Neuroendoscopy allows surgeons to see and remove the hematoma more thoroughly using a small bone flap and a visualized neuroendoscope, aiming to reduce residual hematoma and recurrence. Burr-hole drainage uses a single hole to irrigate and drain the hematoma. Both procedures involve continuous drainage for up to 48 hours post-surgery or until drainage stops naturally. Participants will be adults aged 18 to 90 with diagnosed CSDH requiring surgery. Researchers will assess recurrence rates, mortality, neurological function scales, quality of life, complications, drainage time, and hospital stay length over three months after surgery. Follow-up visits occur at Day 0, Day 2, Month 1, and Month 3 to monitor outcomes and safety. The total study duration per participant is three months post-operation.

Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma